# Internal Review — Round 1

**Reviewer:** Claude Code (Reviewer 2 + Editor)  
**Date:** 2026-01-18  
**Recommendation:** Major Revision

---

## Summary

This paper studies Colorado's unusual two-stage drug policy experiment—decriminalization in 2019 followed by partial recriminalization in 2022. The authors use difference-in-differences comparing Colorado to neighboring states and find no statistically significant effect of either policy change. The topic is timely and policy-relevant. However, several methodological and presentation issues must be addressed before the paper is suitable for a top journal.

---

## Major Concerns

### 1. Pre-Treatment Fit and Identification (Critical)

The paper acknowledges that Colorado had higher overdose rates than neighbors *throughout the sample period* (1.5-2x higher). While the authors note this "does not invalidate DiD identification," readers will be skeptical. **Figure 2 visually suggests Colorado was already diverging from neighbors before 2019.** The 2015-2017 event study coefficients are not statistically different from zero, but they trend upward (-0.08 → -0.04 → +0.02), which is concerning.

**Recommendation:** 
- Report formal tests for pre-trend differences (e.g., joint F-test on pre-treatment coefficients)
- Consider adding state fixed effects and state-specific linear trends
- Discuss whether the level difference implies different drug market dynamics

### 2. Inference with Few Clusters

The paper has only 8 states (1 treated, 7 control) and 10 years. Standard cluster-robust inference is unreliable with so few clusters. The reported standard errors may be too small or too large.

**Recommendation:**
- Implement wild cluster bootstrap (Cameron, Gelbach & Miller 2008)
- Report permutation-based p-values (randomization inference)
- Acknowledge this limitation prominently

### 3. COVID-19 Confounding is Inadequately Addressed

The pandemic arrived in 2020, one year after decriminalization. The paper mentions this as a limitation but does not attempt any adjustment. COVID-19 dramatically disrupted drug markets, treatment access, and mortality—potentially dwarfing any policy effects.

**Recommendation:**
- Add COVID-19 death rates or mobility indices as controls
- Show sensitivity to excluding 2020-2021
- Consider a "pandemic-adjusted" specification

### 4. Mechanism Discussion is Missing

The paper finds a null effect but offers little discussion of *why* possession penalties might not affect overdose deaths. Is it because:
- Users are addicted and unresponsive to legal incentives?
- Enforcement didn't actually change (prosecutors continued charging)?
- The 4-gram threshold was too high to affect typical users?
- Treatment diversion provisions offset any deterrent effect?

**Recommendation:** Add a section discussing potential mechanisms and channels through which policy *could* have affected outcomes, and why these channels may have been weak.

---

## Minor Concerns

### 5. Missing Per-Capita Analysis

All analyses use raw death counts. Colorado's population grew ~10% from 2015-2024. Deaths per 100,000 residents is the standard measure in public health.

**Recommendation:** Add per-capita analysis as robustness check.

### 6. Standard Error Reporting Issue

Table 2 shows enormous standard errors for fentanyl deaths (SE: 1.879 in the two-treatment model). The 95% CI spans -97% to +4,443%. This is not a "precise null"—it's complete uninformativeness. The paper should not claim "precise null" for fentanyl deaths.

**Recommendation:** Revise language to acknowledge that fentanyl-specific estimates are uninformative, not precise nulls.

### 7. Literature Review is Thin

The related literature section is sparse. Missing citations include:
- Oregon Measure 110 evaluations (even if preliminary)
- Recent synthetic opioid literature
- Deterrence theory from criminology

### 8. Figure Quality

Figures are adequate but could be improved:
- Figure 1: Add a note explaining the vertical lines
- Figure 2: Y-axis should start at 0 for honest visual comparison
- Figure 3: Confidence intervals are not visible (standard errors = inf)

---

## Editorial Suggestions

1. The abstract claims results "suggest that demand-side possession penalties have limited effect"—but a null finding with wide CIs doesn't *support* this claim, it simply fails to reject it. Revise to avoid overstating.

2. The paper is 17 pages—quite short for an empirical paper targeting top journals. Consider expanding:
   - Data section (add histograms, more descriptive statistics)
   - Results section (add robustness tables)
   - Discussion of heterogeneity (urban vs. rural, age groups)

3. The bibliography should use a consistent style (currently mixing parenthetical and author-date).

---

## Decision

**Major Revision.** The paper tackles an important question with an interesting natural experiment, but identification concerns (pre-trends, few clusters, COVID confounding) need to be addressed more rigorously. The mechanism discussion should be expanded. With these revisions, the paper could make a contribution to the drug policy literature.

---

## Checklist for Revision

- [ ] Add formal pre-trend test (F-test on pre-treatment event study coefficients)
- [ ] Implement wild cluster bootstrap for inference
- [ ] Add per-capita analysis
- [ ] Discuss mechanisms/channels more thoroughly
- [ ] Revise "precise null" language for fentanyl estimates
- [ ] Address COVID confounding (show sensitivity to excluding 2020-2021)
- [ ] Expand literature review
- [ ] Fix Figure 3 confidence intervals
- [ ] Add state fixed effects specification
